On the NGX board, price is hierarchy. Stanbic is N168. Wema is N31. FCMB is N11. That absolute number is not random. It is the market’s verdict on a bank that has printed its way to survival.
FCMB Group trades around N11.00 to N11.25 today, about 24% above its 52-week low of N9.05 in July 2026 but well below its February high of N14.50. The momentum is tired — down 1.35% in four weeks, up only 5.77% in 12 months, while Zenith delivered over 87% in the same period. This is despite a blowout in reported earnings, with Q2 2026 EPS of N3.84 versus N1.04 a year earlier. When a bank grows earnings by 270% and its share price barely moves, something deeper is broken.
The first layer is dilution, and it is extreme. To meet the CBN’s N500 billion recapitalization order, FCMB expanded its shares outstanding to about 65.95 billion through equity infusions and conversion of mandatory convertible loans. Its market cap today is N725.5 billion. Compare that to Wema with roughly 40 billion shares for N1.24 trillion in market value, and Stanbic with just 16 billion shares for N2.67 trillion. FCMB needs four times Stanbic’s share count to create one-third of its value. When you divide any profit by 65.95 billion, your earnings per share, dividend per share and absolute price will always look depressed. That is why the bank’s three-year price appreciation of 22% to 31% annually has come not from compounding per-share value but from periodic capital raises and institutional volume spikes.
But dilution alone does not explain FCMB. Every bank is diluting. Access Holdings went from 35 billion to 53 billion shares, Fidelity doubled its share count, UBA, GTCO and Zenith all raised capital in the last 18 months. If dilution were the only sin, every bank would be at N11. They are not, because the market judges what you do with the new capital.
That is where FCMB’s second problem shows — weak deployment. GTCO and Zenith can raise N300 billion and the market believes they will deploy it at 25-30% return on equity because of cheap deposits, strong corporate books and large fee income. FCMB’s historical ROE has been 9-13%, with cost-to-income above 60% and heavy reliance on net interest income from a riskier SME and consumer book. Stanbic commands a 2.0x price-to-book premium because it has Standard Bank backing, dominant pension and wealth management income, and high-quality corporate clients. FCMB has no such moat, so it trades at 0.62x to 0.64x book, with book value per share around N17.27. The market values it below its own net assets because it does not trust its ability to sweat those assets. That is why its 3.1x price-to-earnings looks cheap against a peer average of 6.3x and an African banking average of 10.1x, while Wema at 4.8x earnings and 1.7x book is priced as growth and Stanbic at 5.9x earnings is priced as quality.
The third problem is earnings quality. FCMB’s earnings spike is not trusted as sustainable cash. A discounted cash flow model puts its intrinsic future cash flow value at N0.94, meaning at N11 it trades 1,074% above what its cash generation can justify, even as it looks undervalued on P/E. The market has seen this before — FX revaluation gains that reverse, impairments that return, and revenue that fails to convert to free cash flow while capital intensity rises. Wema has been re-rated despite dilution because its ALAT digital play is visibly driving low-cost deposits and fee income. FCMB has not provided that growth narrative.
The final blow is dividend destruction. Yield has collapsed to 3.18% on an expected N0.35 payout, down from 5.50% in FY 2024, because profit must be retained for recapitalization. Stanbic still pays 5.10% and Wema 3.97% with larger market caps. FCMB has therefore delivered the worst combination for shareholders — more shares and less income.
FCMB is not just diluted. It is diluted from a position of weakness, with lower returns, weaker earnings quality, and a disappearing dividend. Other banks diluted to grow. FCMB diluted to survive. Analysts may have a consensus target of N16.04 implying 45% upside, but until return on equity, cost efficiency and cash conversion catch up with its 65.95 billion shares, N11 will not look like a bargain. It will look like a fair price.
